# Corticosteroid Therapy of Septic Shock - Corticus

> **NCT00147004** · PHASE3 · COMPLETED · sponsor: **Hadassah Medical Organization** · enrollment: 500 (actual)

## Conditions studied

- Shock, Septic

## Interventions

- **DRUG:** hydrocortisone sodium succinate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00147004
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2008-04-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00147004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00147004, "Corticosteroid Therapy of Septic Shock - Corticus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00147004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*